Article

Poll: The Top 5 Non–COVID-19 News Stories in 2020

Answer our poll: What do you think was the top non–COVID-19 story in 2020?

The following stories were the most-read news stories on AJMC.com in 2020 that were not related to the coronavirus disease 2019 (COVID-19) pandemic.

FDA's Revised Blood Donation Guidance for Gay Men Still Courts Controversy
FDA Recalls All Ranitidine (Zantac) Products, Citing Increased Risk of Cancer
Fish Oil Debate Continues as Study Finds No Risk Reduction From Omega-3 Combo
FDA Steps Up Warning for Montelukast for Risk of Mental Health Side Effects
Review of Ketamine in ED for Acute Pain Finds Similar Efficacy to Other Pain Relief

Answer our poll by making a choice below – which do you think was the top non–COVID-19 story in 2020?

FDA's Revised Blood Donation Guidance for Gay Men Still Courts Controversy
FDA Recalls All Ranitidine (Zantac) Products, Citing Increased Risk of Cancer
Fish Oil Debate Continues as Study Finds No Risk Reduction From Omega-3 Combo
FDA Steps Up Warning for Montelukast for Risk of Mental Health Side Effects
Review of Ketamine in ED for Acute Pain Finds Similar Efficacy to Other Pain Relief

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
Dr Sundar Jagannath
Michael Hassett, MD, MPH, Dana-Farber Cancer Institute
Senator Vincent Polistina (R, New Jersey)
Rebecca Chacko, MD.
1 expert in this video
Rebecca Chacko, MD, breast medical oncologist at Henry Ford
Amir Fathi, MD, Mass General
Related Content
In chronic lymphocytic leukemia (CLL), TP53 has been an important subject of investigation since the early 1990s. | Image credit: MdBabul - stock.adobe.com
July 25th 2025

TP53 Mutations Remain Important Research Focus in Cancer

Jared Kaltwasser
TP53 mutations can have a significant impact on the prognosis of diseases like chronic lymphocytic leukemia, but their effect can vary based on numerous factors.
managed care cast logo
July 24th 2025

High Costs, Coverage Variability Limit Access to Incretin Mimetics for Weight Management

Brooke McCormick Stephen Lott, PharmD, MS Jonathan Gabison, MD, DABOM
This Managed Care Cast episode explores how high costs and inconsistent insurance coverage for incretin mimetics impact obesity management and patient care.
Acne scar | Image credit: ZAY WIN HTAI - stock.adobe.com
July 24th 2025

Addressing Acne in Patients of Color

Pearl Steinzor
Culturally informed, patient-centered strategies are needed to address acne and hyperpigmentation in patients with skin of color.
Managed Care Cast
Published: July 15th 2025 | Updated: July 15th 2025

Navigating Risk, Treatment, and Reimbursement in Precision Oncology: Sadie Dobrozsi, MD

Giuliana Grossi Sadie Dobrozsi, MD, MS Interview by Mary Caffrey
Sadie Dobrozsi, MD, of Evolent, discusses how predictive genomics is pushing cancer care into a new era of personalization
FDA approval | Image Credit: Maggie-sora.chatgpt.com
July 24th 2025

FDA Approves Delgocitinib for Moderate to Severe Hand Eczema

Maggie L. Shaw
Adult patients with moderate to severe hand eczema with previous treatment failure or in whom topical corticosteroids are contraindicated stand to benefit the most from this approval.
Ruxolitinib cream. | Image Credit: Ladanifer - stock.adobe.com
July 24th 2025

Ruxolitinib Cream Shows Long-Term AD Control in Children Ages 2 to 11

Pearl Steinzor
New data highlight efficacy, safety, and time off treatment with as-needed ruxolitinib cream in pediatric atopic dermatitis.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo